Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension

Susan Mollan; Clare L. Fraser; Kathleen B. Digre; Hans-Christoph  Diener; Richard Lipton; Marianne Juhler; Neil R. Miller; Patricia  Pozo-Rosich; Mansoureh Togha; Kristian Brock; Marc Dinkin; Carmen K. M. Chan; Cristina Tassorelli; Alex Sinclair; Gisela M. Terwindt; Rigmor H Jensen

doi:10.1177/03331024231197118

Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension

Susan Mollan^*, Clare L. Fraser, Kathleen B. Digre, Hans-Christoph Diener, Richard Lipton, Marianne Juhler, Neil R. Miller, Patricia Pozo-Rosich, Mansoureh Togha, Kristian Brock, Marc Dinkin, Carmen K. M. Chan, Cristina Tassorelli, Alex Sinclair, Gisela M. Terwindt, Rigmor H Jensen

^*Corresponding author for this work

Metabolism and Systems Research

Research output: Contribution to journal › Article › peer-review

60 Downloads (Pure)

Abstract

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

Original language	English
Pages (from-to)	1-25
Number of pages	25
Journal	Cephalalgia
Volume	43
Issue number	8
Early online date	3 Sept 2023
DOIs	https://doi.org/10.1177/03331024231197118
Publication status	E-pub ahead of print - 3 Sept 2023

Keywords

raised intracranial pressure
Randomised control trial
Pseudotumor cerebri
papilloedema
Idiopathic intracranial hypertension
drug
Guidelines
lumbar puncture
headache
vision

Access to Document

10.1177/03331024231197118Licence: Creative Commons: Attribution-NonCommercial (CC BY-NC)

MollanS2023Guidelines.pdfFinal published version, 1.01 MBLicence: Creative Commons: Attribution-NonCommercial (CC BY-NC)

Cite this

Mollan, S., Fraser, C. L., Digre, K. B., Diener, H.-C., Lipton, R., Juhler, M., Miller, N. R., Pozo-Rosich, P., Togha, M., Brock, K., Dinkin, M., Chan, C. K. M., Tassorelli, C., Sinclair, A., Terwindt, G. M., & Jensen, R. H. (2023). Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension. Cephalalgia, 43(8), 1-25. Advance online publication. https://doi.org/10.1177/03331024231197118

@article{ca882ee18f5d4795ad7ab852504536ae,

title = "Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension",

abstract = "The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.",

keywords = "raised intracranial pressure, Randomised control trial, Pseudotumor cerebri, papilloedema, Idiopathic intracranial hypertension, drug, Guidelines, lumbar puncture, headache, vision",

author = "Susan Mollan and Fraser, {Clare L.} and Digre, {Kathleen B.} and Hans-Christoph Diener and Richard Lipton and Marianne Juhler and Miller, {Neil R.} and Patricia Pozo-Rosich and Mansoureh Togha and Kristian Brock and Marc Dinkin and Chan, {Carmen K. M.} and Cristina Tassorelli and Alex Sinclair and Terwindt, {Gisela M.} and Jensen, {Rigmor H}",

year = "2023",

month = sep,

day = "3",

doi = "10.1177/03331024231197118",

language = "English",

volume = "43",

pages = "1--25",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "SAGE Publications",

number = "8",

}

Mollan, S, Fraser, CL, Digre, KB, Diener, H-C, Lipton, R, Juhler, M, Miller, NR, Pozo-Rosich, P, Togha, M, Brock, K, Dinkin, M, Chan, CKM, Tassorelli, C, Sinclair, A, Terwindt, GM & Jensen, RH 2023, 'Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension', Cephalalgia, vol. 43, no. 8, pp. 1-25. https://doi.org/10.1177/03331024231197118

TY - JOUR

T1 - Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension

AU - Mollan, Susan

AU - Fraser, Clare L.

AU - Digre, Kathleen B.

AU - Diener, Hans-Christoph

AU - Lipton, Richard

AU - Juhler, Marianne

AU - Miller, Neil R.

AU - Pozo-Rosich, Patricia

AU - Togha, Mansoureh

AU - Brock, Kristian

AU - Dinkin, Marc

AU - Chan, Carmen K. M.

AU - Tassorelli, Cristina

AU - Sinclair, Alex

AU - Terwindt, Gisela M.

AU - Jensen, Rigmor H

PY - 2023/9/3

Y1 - 2023/9/3

N2 - The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

AB - The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

KW - raised intracranial pressure

KW - Randomised control trial

KW - Pseudotumor cerebri

KW - papilloedema

KW - Idiopathic intracranial hypertension

KW - drug

KW - Guidelines

KW - lumbar puncture

KW - headache

KW - vision

UR - https://journals.sagepub.com/home/CEP

U2 - 10.1177/03331024231197118

DO - 10.1177/03331024231197118

M3 - Article

SN - 0333-1024

VL - 43

SP - 1

EP - 25

JO - Cephalalgia

JF - Cephalalgia

IS - 8

ER -

Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension

Abstract

Keywords

Access to Document

Fingerprint

Cite this